These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2669381)

  • 1. Choosing cephalosporins for the formulary.
    Tartaglione TA
    DICP; 1989; 23(7-8 Suppl):S8-12. PubMed ID: 2669381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulary evaluation of third-generation cephalosporins using decision analysis.
    Cano SB; Fujita NK
    Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
    Woodward RS; Medoff G; Smith MD; Gray JL
    Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins.
    Barriere SL
    Am J Hosp Pharm; 1986 Mar; 43(3):625-9. PubMed ID: 3706317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A team approach to hospital formulary replacement.
    Lee J; Carlson JA; Chamberlain MA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):239-42. PubMed ID: 7587047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of cephalosporins for hospital formularies.
    Wilson WR
    Diagn Microbiol Infect Dis; 1995; 22(1-2):129-34. PubMed ID: 7587026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic cost-containment.
    Huckleberry SD
    Drug Intell Clin Pharm; 1986; 20(7-8):589-91. PubMed ID: 3743415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulary decision-making about cephalosporins with similar therapeutic uses.
    Mabe DM
    Am J Health Syst Pharm; 2003 May; 60(10 Suppl 1):S12-5. PubMed ID: 12789882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an antimicrobial formulary change on hospital resistance patterns.
    Empey KM; Rapp RP; Evans ME
    Pharmacotherapy; 2002 Jan; 22(1):81-7. PubMed ID: 11794434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the formulary status of quinolone antibiotics: one institution's approach.
    Nightingale CH; Lubowski T; On A; Quintiliani R
    Hosp Formul; 1992 May; 27(5):509-10, 513-4, 516. PubMed ID: 10128710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic formulary selection.
    Crowe HM; Quintiliani R
    Med Clin North Am; 1995 May; 79(3):463-76. PubMed ID: 7752722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of an antimicrobial control program at a university hospital.
    Martin C; Ofotokun I; Rapp R; Empey K; Armitstead J; Pomeroy C; Hoven A; Evans M
    Am J Health Syst Pharm; 2005 Apr; 62(7):732-8. PubMed ID: 15790801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a cephalosporin education program--a pharmacy education program.
    Sohn CA; Wolter HA; McSweeney GW
    Drug Intell Clin Pharm; 1980 Apr; 14(4):272-7. PubMed ID: 10309192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of decision analysis to drug selection for formulary addition.
    Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H
    Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulary control of antimicrobial usage. What price freedom?
    Dunagan WC; Medoff G
    Diagn Microbiol Infect Dis; 1993; 16(3):265-74. PubMed ID: 8477583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.
    Huang X; Beresford E; Lodise T; Friedland HD
    Am J Health Syst Pharm; 2013 Jun; 70(12):1057-64. PubMed ID: 23719884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.